Chembond Chemicals Limited (CHEMBOND) AI Stock Analysis

• Market Cap: ₹1.89B
• Dividend Yield: 1.11%
• Average Volume (3M): 976.00
• Price to Earnings (P/E): 34.2
• Beta (1Y): 0.35
• Revenue Growth: -37.34%
• EPS Growth: -45.55%
• Country: IN
• Employees: 280
• Sector: Basic Materials
• Sector Strength: 58
• Industry: Chemicals - Specialty
• EPS (TTM): 1.18
• Shares Outstanding: 13,448,288
• 10 Day Avg. Volume: 1,676
• 30 Day Avg. Volume: 976
• PEG Ratio: 0.43
• Price to Book (P/B): 2.76
• Price to Sales (P/S): 2.14
• P/FCF Ratio: 28.11
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 66 Neutral
• Price Target: ₹151.00 ▼(-7.81% Downside)
• Action: Reiterated Date: 01/23/26
• Date: Action: Reiterated 01/23/26

The score is primarily supported by stable financial positioning (strong equity base, low leverage) and improved cash-flow trends, but is held back by volatile revenue/profitability and a neutral-to-weak technical setup (negative MACD and below longer-term moving averages). Valuation is moderate and modestly supportive.

Positive Factors

Balance sheet strength

A strong equity base and low leverage provide durable financial resilience, lowering refinancing risk and enabling the firm to fund working capital or selective capex from internal resources. This stability supports contract performance and long-term supplier/customer confidence across cycles.

Positive cash generation

Consistent positive operating cash flow and improved free cash flow demonstrate the company's ability to convert earnings into usable liquidity. This supports reinvestment, reduces reliance on external debt, and enables measured dividend or capex funding that sustains operations over coming quarters.

Diversified specialty end-markets

Serving multiple industrial end-markets (water treatment, construction, metal finishing) gives structural demand diversification and lowers exposure to any single sector downturn. Specialty product focus also implies technical barriers and customer stickiness that support steady long-term revenue opportunities.

Negative Factors

Sharp revenue decline

A greater-than-50% year-over-year revenue decline is a material structural weakness, eroding scale and operating leverage. Such a drop can indicate lost contracts or demand shifts and will pressure margins, cash generation and the time needed to restore growth absent clear new demand drivers.

Volatile profitability margins

Inconsistent gross and net margins reduce earnings visibility and make long-term planning difficult. Margin volatility signals either pricing power constraints or exposed input-cost pass-through, which can limit free cash flow durability and necessitate operational fixes to sustainably improve returns.

Limited scale and liquidity

Low trading volumes and a modest employee base point to limited scale, which can constrain distribution, R&D investment and bargaining power with large industrial customers. Limited liquidity also raises the cost and complexity of raising capital, slowing strategic expansion or M&A activity.

Chembond Chemicals Limited Business Overview & Revenue Model

Company Description

Chembond Material Technologies Ltd. enages in the manufacture and sell of specialty chemicals. Its products include water treatment, polymers, construction chemicals, coatings, animal nutrition's, and industrial biotech products. The company was founded on March 22, 1975 and is headquartered in Mumbai, India.

How the Company Makes Money

CHEMBOND generates revenue through the manufacturing and sale of specialty chemicals and formulations. Its key revenue streams include the direct sale of construction chemicals, adhesives, and coatings to various industries. The company also benefits from strategic partnerships with other manufacturers and distributors, which expand its market reach and enhance its product offerings. Additionally, CHEMBOND may engage in research and development activities that lead to the introduction of new products, further driving sales and profitability.

Chembond Chemicals Limited Financial Statement Overview

Summary

Financials are mixed: balance sheet strength (low leverage and healthy equity base) supports stability, but revenue and profitability have been volatile. Cash flow remains positive with improved free cash flow, yet inconsistent margins and recent revenue decline limit the score.

Income Statement

Chembond Chemicals has shown a volatile revenue trajectory with a notable decline in the most recent year. The gross profit margin and net profit margin have shown fluctuations, reflecting the company's struggle to maintain consistent profitability. The EBIT and EBITDA margins indicate moderate profitability, suggesting potential for improvement in operational efficiency.

Balance Sheet

The company maintains a strong equity base with a healthy equity ratio, indicating financial stability. The debt-to-equity ratio is low, reflecting prudent leverage management. However, fluctuations in net income have impacted return on equity, suggesting room for improved profitability.

Cash Flow

Despite occasional fluctuations, operating cash flow has remained positive, highlighting potential for stable cash generation. The free cash flow has improved after prior negative figures, indicating better capital expenditure management. The operating cash flow to net income ratio suggests efficient conversion of profits into cash flow.

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	3.60B	2.01B	1.78B	4.40B	3.49B	2.74B
Gross Profit	1.23B	517.72M	317.75M	1.83B	612.28M	1.14B
EBITDA	492.25M	227.48M	203.90M	394.80M	194.10M	334.04M
Net Income	329.32M	175.62M	111.76M	250.96M	139.21M	203.44M
Balance Sheet
Total Assets	0.00	2.02B	4.47B	4.02B	3.61B	3.54B
Cash, Cash Equivalents and Short-Term Investments	345.75M	421.01M	258.61M	370.15M	548.27M	473.20M
Total Debt	0.00	26.46M	68.08M	65.25M	15.06M	18.81M
Total Liabilities	-1.56B	455.74M	842.07M	785.71M	557.71M	596.75M
Stockholders Equity	1.56B	1.56B	3.61B	3.22B	3.04B	2.93B
Cash Flow
Free Cash Flow	0.00	153.54M	155.21M	-124.78M	-42.85M	206.43M
Operating Cash Flow	0.00	197.25M	276.48M	21.67M	-104.71M	250.11M
Investing Cash Flow	0.00	-85.75M	-217.13M	13.56M	-18.68M	-112.22M
Financing Cash Flow	0.00	-87.44M	-50.53M	-20.57M	-40.89M	-19.09M

Chembond Chemicals Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 163.80
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CHEMBOND, the sentiment is Negative. The current price of 163.8 is above the 20-day moving average (MA) of 148.61, above the 50-day MA of 153.73, and below the 200-day MA of 185.76, indicating a bearish trend. The MACD of -3.16 indicates Positive momentum. The RSI at 39.21 is Neutral, neither overbought nor oversold. The STOCH value of 34.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:CHEMBOND.

Chembond Chemicals Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SHREEPUSHK	68 Neutral	₹9.89B	17.66	―	0.52%	28.67%	50.12%
CHEMBOND	66 Neutral	₹1.89B	34.22	―	1.11%	-37.34%	-45.55%
AGARIND	62 Neutral	₹7.55B	95.10	―	0.45%	-4.09%	-32.35%
Sector *	61 Neutral	$10.43B	7.12	-0.05%	2.87%	2.86%	-36.73%
BODALCHEM	60 Neutral	₹5.85B	697.51	―	―	15.56%	2114.71%
IGPL	59 Neutral	₹10.15B	-28.19	―	2.59%	-10.71%	-40.89%
FAIRCHEMOR	47 Neutral	₹7.20B	-2,425.33	―	1.07%	-22.10%	-85.56%

Chembond Chemicals Limited Corporate Events

Chembond Material Technologies Publishes Unaudited Q3 FY26 Results in Newspapers

Chembond Material Technologies Limited has notified the stock exchanges that it has published the extract of its unaudited financial results for the quarter and nine months ended December 31, 2025 in the English daily Business Standard on January 17, 2026 and the Marathi daily Mumbai Lakshdeep on January 18, 2026. The disclosure, made under SEBI’s listing regulations, underscores the company’s compliance with statutory transparency and reporting requirements for listed entities, ensuring that investors and other stakeholders have public access to its latest financial performance data.